FALLS CHURCH, Va., April 6, 2020 /PRNewswire-PRWeb/ -- Form
483s Database
https://www.fdanews.com/483offer
Is one prepared enough for when an FDA investigat or shows up at
the door for an inspection? Is one worried about 483s and passing
the FDA good manufacturing practices, good clinical practices or
preapproval inspections? Does one want to know what the
investigator is looking for?
Subscribe to Form 483s Database. This database enables
subscribers to learn from others' inspections mistakes, gives
subscribers a step up and helps subscribers avoid low-quality
suppliers.
This comprehensive resource takes the mystery out of 483s,
providing thousands of 483s examples received by companies, labs,
trial sites and investigators over the past decade.
With unlimited access subscribers can:
•Learn in advance about the people who conduct FDA inspections:
Does an investigator take a special interest in one area or
another?
•Discover how many companies in a region or area of business have
turned in less-than-stellar inspection performances recently: Is
there a trend that can help one be proactive in fixing the
company's problems?
•Understand how the FDA describes violations and noncompliance
issues: What does the agency mean by terms such as failure to
follow written procedures, lack of complaint investigation and
corrective and preventive action?
The Form 483s Database is an essential tool to prepare for the
next inspection. It's robust with thousands of downloadable 483s;
fully searchable by date, category, company name, investigator
name, region and key words; and up-to-date with new documents added
each week.
Start a one-year subscription to Form 483s Database for only
$997. Be prepared to ace the next
inspection and stay in compliance!
Database Details:
Form 483s Database
https://www.fdanews.com/483offer
Database:
$997 per site
Easy Ways to Register:
Online: https://www.fdanews.com/483offer
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international
regulatory, legislative, and business news and information for
executives in industries regulated by the US FDA and the European
Medicines Agency. Pharmaceutical and medical device professionals
rely on FDAnews' print and electronic newsletters, books and
conferences to stay in compliance with international standards and
the FDA's complex and ever-changing regulations
SOURCE FDAnews